Unknown

Dataset Information

0

Integrated proteomics and metabolomics reveals the comprehensive characterization of antitumor mechanism underlying Shikonin on colon cancer patient-derived xenograft model.


ABSTRACT: Colorectal cancer (CRC) is a common malignancy occurring in the digestive system. Despite progress in surgery and therapy options, CRC is still a considerable cause of cancer mortality worldwide. In this study, a colon cancer patient-derived xenograft model was established to evaluate the antitumor activity of Shikonin. The protective effect underlying Shikonin was determined through assessing serum levels of liver enzymes (ALT, AST) and kidney functions (BuN, Scr) in PDX mice. Proteomics and metabolomics profiles were integrated to provide a systematic perspective in dynamic changes of proteins and global endogenous metabolites as well as their perturbed pathways. A total of 456 differently expressed proteins (DEPs), 32 differently expressed metabolites (DEMs) in tumor tissue, and 20 DEMs in mice serum were identified. The perturbation of arginine biosynthesis, purine metabolism, and biosynthesis of amino acids may mainly account for therapeutic mechanism of Shikonin. Furthermore, the expression of mRNAs participating in arginine biosynthesis (CPS1, OTC, Arg1) and do novo purine synthesis (GART, PAICS, ATIC) were validated through RT-qPCR. Our study provides new insights into the drug therapeutic strategies and a better understanding of antitumor mechanisms that might be valuable for further studies on Shikonin in the clinical treatment of colorectal cancer.

SUBMITTER: Chen Y 

PROVIDER: S-EPMC7445290 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Integrated proteomics and metabolomics reveals the comprehensive characterization of antitumor mechanism underlying Shikonin on colon cancer patient-derived xenograft model.

Chen Yang Y   Ni Juan J   Gao Yun Y   Zhang Jinghui J   Liu Xuesong X   Chen Yong Y   Chen Zhongjian Z   Wu Yongjiang Y  

Scientific reports 20200824 1


Colorectal cancer (CRC) is a common malignancy occurring in the digestive system. Despite progress in surgery and therapy options, CRC is still a considerable cause of cancer mortality worldwide. In this study, a colon cancer patient-derived xenograft model was established to evaluate the antitumor activity of Shikonin. The protective effect underlying Shikonin was determined through assessing serum levels of liver enzymes (ALT, AST) and kidney functions (BuN, Scr) in PDX mice. Proteomics and me  ...[more]

Similar Datasets

| S-EPMC7689381 | biostudies-literature
| S-EPMC7568555 | biostudies-literature
| S-EPMC6278518 | biostudies-other
| S-EPMC5009432 | biostudies-literature
2016-01-06 | E-GEOD-68881 | biostudies-arrayexpress
| S-EPMC8551455 | biostudies-literature
2024-09-13 | GSE234709 | GEO
2016-01-06 | GSE68881 | GEO
| S-EPMC4007108 | biostudies-literature
| S-EPMC8189116 | biostudies-literature